Compare, Analyse Elder Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   MYLAN
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
MYLAN
Dec-18
ELDER PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3803,487-   
Low Rs1881,919-   
Sales per share (Unadj.) Rs491.21,604.4-  
Earnings per share (Unadj.) Rs-3.243.6-  
Cash flow per share (Unadj.) Rs14.4344.0-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.51,735.6-  
Shares outstanding (eoy) m20.54514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.7 34.3%   
Avg P/E ratio x-89.362.0 -143.9%  
P/CF ratio (eoy) x19.77.9 250.8%  
Price / Book Value ratio x0.81.6 48.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8331,390,655 0.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM23,584.4-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM640.4-  
INCOME DATA
Net Sales Rs m10,089825,454 1.2%  
Other income Rs m2570-   
Total revenues Rs m10,346825,454 1.3%   
Gross profit Rs m-792213,597 -0.4%  
Depreciation Rs m361154,558 0.2%   
Interest Rs m2,75639,702 6.9%   
Profit before tax Rs m-3,65319,338 -18.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-3,077 -4.1%   
Profit after tax Rs m-6522,415 -0.3%  
Gross profit margin %-7.825.9 -30.3%  
Effective tax rate %-3.4-15.9 21.5%   
Net profit margin %-0.62.7 -23.9%  
BALANCE SHEET DATA
Current assets Rs m9,240460,933 2.0%   
Current liabilities Rs m9,998336,071 3.0%   
Net working cap to sales %-7.515.1 -49.6%  
Current ratio x0.91.4 67.4%  
Inventory Days Days4684 55.4%  
Debtors Days Days6093 64.2%  
Net fixed assets Rs m10,124160,125 6.3%   
Share capital Rs m206440 46.8%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,734892,991 0.9%   
Long term debt Rs m4,889963,824 0.5%   
Total assets Rs m22,8822,395,348 1.0%  
Interest coverage x-0.31.5 -21.9%   
Debt to equity ratio x0.61.1 58.6%  
Sales to assets ratio x0.40.3 127.9%   
Return on assets %11.82.6 453.5%  
Return on equity %-0.82.5 -33.7%  
Return on capital %22.33.2 701.7%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754171,530 6.9%  
From Investments Rs m-561-88,662 0.6%  
From Financial Activity Rs m-6,762-79,908 8.5%  
Net Cashflow Rs m4,4321,421 311.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.25 Rs / USD

Compare ELDER PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: PFIZER  JUBILANT PHARMOVA   FDC  NATCO PHARMA  SUN PHARMA  



Today's Market

Maruti Extends Production Shutdown, Avenue Supermarts Q4 Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended higher yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 296 points (up 0.6%).

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ELDER PHARMA

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS